trending Market Intelligence /marketintelligence/en/news-insights/trending/xukchqjfk5sqwkt_uifila2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Kura Oncology closes $77.1M stock offering

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Kura Oncology closes $77.1M stock offering

Kura Oncology Inc. closed its public offering to raise about $77.1 million in gross proceeds.

The San Diego-based biopharmaceutical company issued 4.6 million common shares at $16.75 apiece, which included 600,000 shares bought by the underwriters after they exercised their option in full.

Leerink Partners acted as sole book-running manager for the offering.